• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌的遗传见解和治疗潜力:KRAS 基因的突变分析和橄榄苦苷结合氧化铁纳米颗粒的疗效。

Genetic insights and therapeutic potential for colorectal cancer: mutation analysis of KRAS gene and efficacy of Oleuropein-conjugated iron oxide nanoparticles.

机构信息

Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran.

Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8771-8783. doi: 10.1007/s00210-024-03182-9. Epub 2024 Jun 5.

DOI:10.1007/s00210-024-03182-9
PMID:38837069
Abstract

This study aimed to address the challenges of treating advanced stages of colon cancer (CRC) by exploring potential therapeutic options. The research focused on the genetic aspects of CRC, specifically the mutation rate of the KRAS gene, along with other genes like TTN, APC, MUC16, and TP53, using the TCGA dataset. Additionally, the study investigated the efficacy of Oleuropein, a polyphenolic compound found in olives, in combating CRC by using iron oxide nanoparticles coated with glucose and conjugated with Oleuropein. The study characterized the physicochemical properties of the nanoparticles, and the cytotoxic effects of the nanoparticles were evaluated on CRC and normal fibroblast cell lines, demonstrating significantly higher cytotoxicity against CRC cells compared to normal cells. Furthermore, the study analyzed gene expression changes using the GSE124627 dataset to understand the influence of KRAS alterations. It identified numerous upregulated and downregulated genes in KRAS-overexpressing samples, suggesting their involvement in critical cancer-related pathways. These findings suggest that KRAS-influenced genes could serve as potential therapeutic targets for CRC treatment. The study also examined the expression levels of identified genes in CRC samples compared to normal samples. Among the upregulated genes, 22 showed significant increases in cancer samples, while 14 downregulated genes exhibited decreased expression in both KRAS-influenced and cancer samples. Cox regression analysis identified specific upregulated genes, including ANKZF1, SNAI1, PPFIA4, SIX4, and NOTUM, associated with poor prognosis. Kaplan-Meier analysis further confirmed the correlation between increased expression of these genes and higher patient mortality rates. In conclusion, this study provided valuable insights into the genetic aspects of CRC and potential therapeutic strategies. The use of Oleuropein-conjugated iron oxide nanoparticles showed promising cytotoxic effects on colon cancer cells. These findings contribute to advancing our understanding of CRC and offer potential targets for further investigation and the development of novel therapeutic approaches.

摘要

本研究旨在通过探索潜在的治疗选择来解决晚期结肠癌(CRC)的治疗挑战。该研究专注于 CRC 的遗传方面,特别是 KRAS 基因的突变率,以及使用 TCGA 数据集的其他基因,如 TTN、APC、MUC16 和 TP53。此外,该研究还研究了橄榄叶中发现的多酚化合物橄榄苦苷,通过用葡萄糖涂覆的氧化铁纳米粒子并与橄榄苦苷结合,来对抗 CRC 的疗效。该研究对纳米粒子的物理化学性质进行了表征,并在 CRC 和正常成纤维细胞系上评估了纳米粒子的细胞毒性作用,结果表明,与正常细胞相比,纳米粒子对 CRC 细胞具有明显更高的细胞毒性。此外,该研究还使用 GSE124627 数据集分析了基因表达变化,以了解 KRAS 改变的影响。它确定了 KRAS 过表达样本中许多上调和下调的基因,表明它们参与了关键的癌症相关途径。这些发现表明,KRAS 影响的基因可能成为 CRC 治疗的潜在治疗靶点。该研究还检查了 CRC 样本与正常样本中鉴定的基因的表达水平。在上调的基因中,有 22 个在癌症样本中显著增加,而在受 KRAS 影响的样本和癌症样本中表达下调的有 14 个基因。Cox 回归分析确定了特定的上调基因,包括 ANKZF1、SNAI1、PPFIA4、SIX4 和 NOTUM,与预后不良相关。Kaplan-Meier 分析进一步证实了这些基因表达增加与患者死亡率升高之间的相关性。总之,本研究为 CRC 的遗传方面和潜在的治疗策略提供了有价值的见解。用橄榄苦苷结合的氧化铁纳米粒子对结肠癌细胞表现出有希望的细胞毒性作用。这些发现有助于我们深入了解 CRC,并为进一步研究和开发新的治疗方法提供了潜在的目标。

相似文献

1
Genetic insights and therapeutic potential for colorectal cancer: mutation analysis of KRAS gene and efficacy of Oleuropein-conjugated iron oxide nanoparticles.结直肠癌的遗传见解和治疗潜力:KRAS 基因的突变分析和橄榄苦苷结合氧化铁纳米颗粒的疗效。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov;397(11):8771-8783. doi: 10.1007/s00210-024-03182-9. Epub 2024 Jun 5.
2
Exploring the Therapeutic Potential of FeO@Glu-Oleuropein Nanoparticles in Targeting KRAS Pathway-Regulating lncRNAs in Colorectal Cancer Cells.探索 FeO@Glu-Oleuropein 纳米颗粒在靶向调控结直肠癌细胞 KRAS 通路长链非编码 RNA 中的治疗潜力。
Biol Trace Elem Res. 2024 Jul;202(7):3073-3085. doi: 10.1007/s12011-023-03892-w. Epub 2023 Oct 4.
3
In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.在突变型 KRAS 的结直肠癌细胞中,SLC25A22 介导的谷氨酰胺分解作用降低 DNA 去甲基化以增加 WNT 信号、干性和耐药性。
Gastroenterology. 2020 Dec;159(6):2163-2180.e6. doi: 10.1053/j.gastro.2020.08.016. Epub 2020 Aug 16.
4
4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis.4-乙酰基-安石榴苷 B 通过调节 Ras/Raf/miR-193a-3p 信号轴改善西妥昔单抗对 Kras 突变型和野生型结直肠癌的增敏作用。
Int J Mol Sci. 2021 Jul 14;22(14):7508. doi: 10.3390/ijms22147508.
5
Fecal gene detection based on next generation sequencing for colorectal cancer diagnosis.基于下一代测序的粪便基因检测用于结直肠癌诊断。
World J Gastroenterol. 2022 Jul 7;28(25):2920-2936. doi: 10.3748/wjg.v28.i25.2920.
6
Relationships among mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer.结直肠癌患者突变状态、RAS 通路信号分子表达与临床病理特征和预后的关系。
World J Gastroenterol. 2019 Feb 21;25(7):808-823. doi: 10.3748/wjg.v25.i7.808.
7
The response of PIK3CA/KRAS-mutant colorectal cancer stem-like cells to RGD-peptide FraC produced by the strawberry anemone: A promising water-soluble peptide-based inhibitor of metastasis-driver gene CXCR4, stem cell regulatory genes and self-renewal.PIK3CA/KRAS 突变型结直肠肿瘤干细胞样细胞对草莓海葵产生的 RGD 肽 FraC 的反应:一种有前途的基于水溶性肽的 CXCR4 转移驱动基因、干细胞调节基因和自我更新抑制剂。
Biomed Pharmacother. 2020 Dec;132:110807. doi: 10.1016/j.biopha.2020.110807. Epub 2020 Oct 15.
8
MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.miRNA-425-5p 的表达影响结直肠癌中的 BRAF/RAS/MAPK 通路。
Int J Med Sci. 2019 Oct 11;16(11):1480-1491. doi: 10.7150/ijms.35269. eCollection 2019.
9
COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS.COL1A1:表达野生型或突变型 KRAS 的结直肠癌的潜在治疗靶点。
Int J Oncol. 2018 Nov;53(5):1869-1880. doi: 10.3892/ijo.2018.4536. Epub 2018 Aug 22.
10
Qualitative Ras pathway signature for cetuximab therapy reveals resistant mechanism in colorectal cancer.表皮生长因子受体(EGFR)通路抑制剂西妥昔单抗在结直肠癌中的疗效预测标志物。
FEBS J. 2020 Dec;287(23):5236-5248. doi: 10.1111/febs.15306. Epub 2020 Apr 20.

引用本文的文献

1
From Olive Tree to Treatment: Nano-Delivery Systems for Enhancing Oleuropein's Health Benefits.从橄榄树到治疗:用于增强橄榄苦苷健康益处的纳米递送系统
Pharmaceuticals (Basel). 2025 Apr 15;18(4):573. doi: 10.3390/ph18040573.

本文引用的文献

1
Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction.通过从松萝生物活性部分合成的银纳米粒子诱导肺癌和前列腺癌细胞凋亡。
J Biol Inorg Chem. 2020 Feb;25(1):23-37. doi: 10.1007/s00775-019-01729-3. Epub 2019 Oct 23.
2
Synthesis of Nano-Paramagnetic Oleuropein to Induce KRAS Over-Expression: A New Mechanism to Inhibit AGS Cancer Cells.纳米顺磁橄榄苦苷的合成诱导 KRAS 过表达:抑制 AGS 癌细胞的新机制。
Medicina (Kaunas). 2019 Jul 19;55(7):388. doi: 10.3390/medicina55070388.
3
High expression is associated with poor overall survival and recurrence-free survival in colon cancer.
高表达与结肠癌患者的总生存和无复发生存不良相关。
Future Oncol. 2019 Jun;15(18):2093-2106. doi: 10.2217/fon-2018-0920. Epub 2019 Jul 1.
4
Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations.mTOR 信号通路的改变影响 BRAF 和 KRAS 突变的结直肠癌对代谢应激的抵抗力。
Sci Rep. 2018 Jun 15;8(1):9204. doi: 10.1038/s41598-018-27394-1.
5
Anticancer effects of oleuropein.橄榄苦苷的抗癌作用。
Biofactors. 2017 Jul 8;43(4):517-528. doi: 10.1002/biof.1366. Epub 2017 Jun 14.
6
Chemopreventive effect of oleuropein in colitis-associated colorectal cancer in c57bl/6 mice.橄榄苦苷对C57BL/6小鼠结肠炎相关结直肠癌的化学预防作用。
Mol Nutr Food Res. 2016 Feb;60(2):242-55. doi: 10.1002/mnfr.201500605. Epub 2015 Oct 26.
7
Mutant KRAS as a critical determinant of the therapeutic response of colorectal cancer.突变型KRAS作为结直肠癌治疗反应的关键决定因素。
Genes Dis. 2015 Mar;2(1):4-12. doi: 10.1016/j.gendis.2014.10.002.
8
Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1α.没食子酸橄榄苦苷,一种来源于橄榄树的裂环环烯醚萜,可通过下调 HIF-1α 抑制人结直肠癌细胞的增殖。
Nutr Cancer. 2013;65(1):147-56. doi: 10.1080/01635581.2013.741758.
9
Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis.结肠癌治疗的前景与联合方法增强癌细胞凋亡的范围。
Crit Rev Oncol Hematol. 2013 Jun;86(3):232-50. doi: 10.1016/j.critrevonc.2012.09.014. Epub 2012 Oct 23.
10
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.结直肠癌中 KRAS 突变的出现和抗 EGFR 治疗的获得性耐药。
Nature. 2012 Jun 28;486(7404):532-6. doi: 10.1038/nature11156.